Regulus Therapeutics Inc. Gains 54.83%
Wed, May 11, 2022 at 05:30 PM
Regulus Therapeutics Inc. (RGLS:NASDAQ) jumped higher at $0.27, a gain of 54.8%. The stock appeared on our News Catalysts scanner on Wed, May 11, 2022 at 09:56 AM in the 'BIOTECH' category. From Tue, Apr 26, 2022, the stock recorded 10.00% Up Days and 9.09% Green Days
The stock spiked on Mon, Apr 04, 2022 at $0.37 with a volume of 2M+.
About Regulus Therapeutics Inc. (RGLS:NASDAQ)
Regulus Therapeutics Inc is a biotechnology company that focuses on the development of microRNA therapies. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome.
Top 10 Gainers:
- Armstrong Flooring, Inc. (AFI:NYSE), 237%
- Regulus Therapeutics Inc. (RGLS:NASDAQ), 54.83%
- Lixiang Education Holding Co. Ltd. (LXEH:NASDAQ), 50%
- Sunlands Technology Group (STG:NYSE), 34.29%
- Trecora Resources (TREC:NYSE), 25.96%
- Lianluo Smart Limited (LLIT:NASDAQ), 24.59%
- Inspired Entertainment, Inc. (INSE:NASDAQ), 21.3%
- Regis Corporation (RGS:NYSE), 20.11%
- Cabot Oil & Gas Corporation (COG:NYSE), 20.08%
- H&R Block, Inc. (HRB:NYSE), 19.52%